Personalized cancer nanomedicine: Overcoming biological barriers for intracellular delivery of biopharmaceuticals
AM López‐Estévez, P Lapuhs… - Advanced …, 2024 - Wiley Online Library
The success of personalized medicine in oncology relies on using highly effective and
precise therapeutic modalities such as small interfering RNA (siRNA) and monoclonal …
precise therapeutic modalities such as small interfering RNA (siRNA) and monoclonal …
Mitochondria deregulations in cancer offer several potential targets of therapeutic interventions
C Musicco, A Signorile, V Pesce… - International Journal of …, 2023 - mdpi.com
Mitochondria play a key role in cancer and their involvement is not limited to the production
of ATP only. Mitochondria also produce reactive oxygen species and building blocks to …
of ATP only. Mitochondria also produce reactive oxygen species and building blocks to …
Graphene-Based Nanomaterials for Photothermal Therapy in Cancer Treatment
DF Báez - Pharmaceutics, 2023 - mdpi.com
Graphene-based nanomaterials (GBNMs), specifically graphene oxide (GO) and reduced
graphene oxide (rGO), have shown great potential in cancer therapy owing to their …
graphene oxide (rGO), have shown great potential in cancer therapy owing to their …
[HTML][HTML] Evaluation of biogenically synthesized MgO NPs anticancer activity against breast cancer cells
MR Khan, NO Alafaleq, AK Ramu, K Alhosaini… - Saudi Journal of …, 2024 - Elsevier
Background Magnesium is recognized to have pharmacological potential, and its
nanoformulation is anticipated to offer significant therapeutic effects, particularly against …
nanoformulation is anticipated to offer significant therapeutic effects, particularly against …
Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review
S Sun, Y Wang, X Gao, H Wang, L Zhang… - … in Bioengineering and …, 2023 - frontiersin.org
The treatment of breast cancer (BC) is a serious challenge due to its heterogeneous nature,
multidrug resistance (MDR), and limited therapeutic options. Nanoparticle-based drug …
multidrug resistance (MDR), and limited therapeutic options. Nanoparticle-based drug …
QbD-optimized, phospholipid-based elastic nanovesicles for the effective delivery of 6-Gingerol: a promising topical option for pain-related disorders
In this study, elastic nanovesicles, constructed of phospholipids optimized by Quality by
Design (QbD), release 6-gingerol (6-G), a natural chemical that may alleviate osteoporosis …
Design (QbD), release 6-gingerol (6-G), a natural chemical that may alleviate osteoporosis …
Deep eutectic solvent based self-healable, stretchable and injectable eutectogels: A versatile platform for breast cancer treatment
Recent focus is on developing cancer treatments that overcome challenges of high-dose
chemotherapy, providing improved safety, effectiveness, and site-specific targeting through …
chemotherapy, providing improved safety, effectiveness, and site-specific targeting through …
Stimuli-Responsive Polymeric Nanomedicine for Enhanced Cancer Immunotherapy
Cancer immunotherapy, aimed at reinvigorating the immune system to induce a lasting
anticancer response, has emerged as a promising approach for counteracting the evasive …
anticancer response, has emerged as a promising approach for counteracting the evasive …
Nanomedicines: Emerging Platforms in Smart Chemotherapy Treatment—A Recent Review
Cancer continues to pose one of the most critical challenges in global healthcare. Despite
the wide array of existing cancer drugs, the primary obstacle remains in selectively targeting …
the wide array of existing cancer drugs, the primary obstacle remains in selectively targeting …
A Direct Comparison of Peptide Drug Delivery Systems Based on the Use of Hybrid Calcium Phosphate/Chitosan Nanoparticles versus Unmixed Calcium Phosphate …
E Popova, V Tikhomirova, O Beznos… - International Journal of …, 2023 - mdpi.com
Nanocarriers provide a number of undeniable advantages that could improve the
bioavailability of active agents for human, animal, and plant cells. In this study, we compared …
bioavailability of active agents for human, animal, and plant cells. In this study, we compared …